DIN 02468816 — IMFINZI 50 MG
IMFINZI is a solution of Durvalumab marketed by ASTRAZENECA CANADA INC. The full Durvalumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02468816
- Brand name
- IMFINZI
- Active ingredient
- Durvalumab
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent, monoclonal antibody (PD-L1 inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.